Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-018782

Chief Business Officer sold 44,000 shares at an average $21.78 ($958,220)

  • Chief Business Officer acquired 44,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Martin Michael Robert Chief Business Officer 2021-09-14 Option exercise +44,000 $5.30 $233,200 220,861 D: show line 1 in the form
Martin Michael Robert Chief Business Officer 2021-09-14 Sale −14,000 $21.73 $304,220 206,861 D: show line 2 in the form
Martin Michael Robert Chief Business Officer 2021-09-14 Sale −30,000 $21.80 $654,000 176,861 D: show line 3 in the form
Open-market sales · 44,000 sh · avg $21.78 · $958,220

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Martin Michael Robert Chief Business Officer 2021-09-14 Option exercise · Option Grant (right to buy) −44,000 36,000 D: show line 4 in the form
Loading xslF345X03/wf-form4_163182609831779.xml…